Yahoo Finance • 24 days ago
* NuCana (NASDAQ:NCNA [https://seekingalpha.com/symbol/NCNA]) on Friday said it has received formal notification from Nasdaq, confirming that the company is in compliance with all applicable continued listing criteria, including the $1.0... Full story
Yahoo Finance • 24 days ago
EDINBURGH, United Kingdom, Sept. 05, 2025 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) (“NuCana” or the “Company”) announced that it has received formal notification from The Nasdaq Stock Market on September 4, 2025 confirming that the... Full story
Yahoo Finance • 26 days ago
EDINBURGH, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) (“NuCana” or the “Company”) announced a presentation at the upcoming annual European Society for Medical Oncology (“ESMO”) congress being held Octobe... Full story
Yahoo Finance • last month
First Patients Dosed on Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data in 2026 Addit... Full story
Yahoo Finance • last month
Investing.com - H.C. Wainwright raised its price target on Editas Medicine (NASDAQ:EDIT) to $5.00 from $3.00 on Friday, while maintaining a Buy rating on the gene editing company’s stock. The upgrade comes as Editas shares have surged over... Full story
Yahoo Finance • 2 months ago
Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today. [mostactive] TODAY'S MOST ACTIVE STOCKS TICKER CHANGE COMMENT OPEN [https://www.chartmill.com/stock/qu... Full story
Yahoo Finance • 2 months ago
Curious about the most active stocks on Tuesday? Find out which stocks are dominating the market action! [mostactive] MOST ACTIVE STOCKS TICKER CHANGE COMMENT GIBO [https://www.chartmill.com/stock/quote/GIBO/profile] 44.2%... Full story
Yahoo Finance • 2 months ago
These stocks are making the most noise in today's session. Stay tuned for the latest updates! [mostactive] TODAY'S MOST ACTIVE STOCKS TICKER CHANGE COMMENT GIBO [https://www.chartmill.com/stock/quote/GIBO/profile] 24.36%... Full story
Yahoo Finance • 2 months ago
These stocks are making the most noise in today's session. Stay tuned for the latest updates! [mostactive] MOST ACTIVE STOCKS TICKER CHANGE COMMENT HCTI [https://www.chartmill.com/stock/quote/HCTI/profile] 74.6% So far, a... Full story
Yahoo Finance • 2 months ago
EDINBURGH, United Kingdom, July 21, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announces it has successfully canceled all remaining Series A Warrants, issued in the registered direct offering on May 7,... Full story
Yahoo Finance • 3 months ago
EDINBURGH - NuCana plc (NASDAQ:NCNA) announced Friday it will change the ratio of its American Depositary Shares (ADSs) to ordinary shares from 1:25 to 1:5,000, effectively creating a 1:200 reverse ADS split. According to InvestingPro data... Full story
Yahoo Finance • 3 months ago
EDINBURGH, United Kingdom, July 11, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, re... Full story
Yahoo Finance • 3 months ago
NuCana plc (NASDAQ:NCNA) announced today that Chief Executive Officer Hugh S. Griffith will be taking a leave of absence due to health reasons, effective immediately. Griffith is expected to return to his duties later this year. The comp... Full story
Yahoo Finance • 4 months ago
* NuCana press release [https://seekingalpha.com/pr/20123467-nucana-reports-first-quarter-2025-financial-results-and-provides-business-update] (NASDAQ:NCNA [https://seekingalpha.com/symbol/NCNA]): Q1 GAAP EPS of -£0.02. * As of March 3... Full story
Yahoo Finance • 4 months ago
Initiation of Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data in 2026 Additional Data... Full story
Yahoo Finance • 6 months ago
Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025 Data from the Expansion Study to Support Interaction with FDA and Define Regulatory... Full story
Yahoo Finance • last year
Investing.com – U.S. stocks were higher after the close on Friday, as gains in the Consumer Services, Consumer Goods and Industrials sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average added 0.55% to hit a ne... Full story
Yahoo Finance • 2 years ago
Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Data Pipeline Continues to Advance with Data Updates Expected for all Programs in 2024 Well Capitalized with Anticipated Cash Runway int... Full story
Yahoo Finance • 2 years ago
EDINBURGH, United Kingdom, Nov. 10, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced today that it has received approval from Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”)... Full story
Yahoo Finance • 2 years ago
EDINBURGH, United Kingdom, Nov. 08, 2023 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the... Full story